A Study to Evaluate Preventive Treatments for GPRC5D-related Oral Events

Clinical trial NCT06500884 · RECRUITING

Trial details

NCT number: NCT06500884
Sponsor: Janssen Research & Development, LLC
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2024-08-26
Primary completion: 2030-05-30
Enrollment: 210

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.